|
HS Code |
130748 |
| Iupac Name | 1-(4-fluorophenyl)pentan-1-one |
| Molecular Formula | C11H13FO |
| Molar Mass | 180.22 g/mol |
| Cas Number | 2363-64-2 |
| Appearance | Colorless to pale yellow liquid |
| Boiling Point | 257-259 °C |
| Melting Point | N/A |
| Density | 1.07 g/cm³ |
| Solubility In Water | Low |
| Flash Point | 101.7 °C |
| Refractive Index | 1.499 |
| Smiles | CCCCC(=O)C1=CC=C(C=C1)F |
As an accredited 4'-Fluorovalerophenone factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | 100g of 4'-Fluorovalerophenone is supplied in a sealed amber glass bottle, labeled with product details, CAS number, and hazard warnings. |
| Shipping | 4'-Fluorovalerophenone is typically shipped in tightly sealed containers, protected from moisture and light, under ambient conditions. Packaging follows relevant hazardous material regulations due to its chemical nature. Each shipment includes proper labeling and documentation to comply with safety guidelines and ensure secure transit to the destination. |
| Storage | 4'-Fluorovalerophenone should be stored in a tightly sealed container, in a cool, dry, and well-ventilated area away from direct sunlight. It should be kept away from sources of ignition, oxidizing agents, and incompatible substances. Store it at room temperature, and ensure appropriate labeling and secure shelving. Access should be restricted to trained personnel only, following standard chemical safety protocols. |
Applications of 4'-Fluorovalerophenone in Industrial Manufacturing4'-Fluorovalerophenone serves as a specialty intermediate within several established chemical manufacturing streams. Its downstream demand arises predominantly from pharmaceutical synthesis, fine chemical production, agrochemical intermediates, advanced materials research, and specialty perfumery components. The following application segments detail typical industry practices and regulatory environments, emphasizing precise formulation and strict compliance found in B2B settings. 1. Pharmaceutical Intermediate for CNS Active Compounds4'-Fluorovalerophenone is used in API synthesis for central nervous system (CNS) drug candidates where a fluorinated side chain is critical to pharmacological activity. It typically enters the process in the early stages of multi-step synthesis. Our clients deploy it as a building block to introduce a fluorinated moiety in the phenone backbone, supporting research and production of investigational and registered drugs. Handling procedures must align with stringent cGMP requirements and robust analytical monitoring. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
2. Fine Chemical Manufacturing for Specialty KetonesChemical plants incorporate 4'-Fluorovalerophenone as a starting material for synthesizing high-value specialty ketones used in analytical reagents and organic synthesis aids. This application requires precise stoichiometric calculations to manage cost and end-point purity, with close attention to environmental exposure and traceable batch control. Most facilities implementing this route maintain ISO-based quality and environmental systems. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
3. Agrochemical Intermediate Production4'-Fluorovalerophenone is adopted by agrochemical companies to deliver high-purity intermediates necessary for active ingredient synthesis. Florinated motifs help modify activity spectra and improve field stability of crop protection products. Application at this stage mandates thorough control over impurities, as downstream ecological and toxicological evaluations demand precise ingredient profiling. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
4. Advanced Materials Chemistry – Liquid Crystal and Display IntermediatesWithin advanced materials research, laboratories select 4'-Fluorovalerophenone for introducing defined fluorinated aromatic groups in liquid crystal compositions. This application focuses on modifying the electro-optical properties of display molecules, requiring exceptional traceability and solvent purity. Batch reporting ties to device-grade quality control and electronic material certifications. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
5. Fragrance Ingredient Synthesis for High-End PerfumerySpecialty perfumery manufacturers integrate 4'-Fluorovalerophenone into synthesis of unique olfactory molecules where a fluorinated group imparts enhanced volatility and stability. This use requires close coordination with IFRA guidelines and allergen management practices to validate human exposure levels. Small-scale, batch-controlled production dominates, with each batch linked to full origin and composition verification. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
|
Competitive 4'-Fluorovalerophenone prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
4'-Fluorovalerophenone, also known as 1-(4-Fluorophenyl)-1-pentanone, stands out from the long line of aryl ketones produced at our facility. After years of refining synthesis techniques, process controls, and purification methods, we now provide a material that has gained real recognition among researchers and process chemists alike. Working closely with clients and keeping an eye on development in fine chemicals and pharmaceutical sectors guides each stage of our own production. Unlike many traders who simply pass along standard product sheets, we start every batch with the end application in mind—and that changes how it performs on your bench or in your plant.
Within our plant, every run of 4'-Fluorovalerophenone undergoes targeted monitoring. Rigorous GC-MS and NMR protocols define specification boundaries, meeting benchmarks typical for active pharmaceutical intermediate (API) research and catalyst development studies. Purity runs at 99% and above by GC. Moisture and residual solvent content remain below industry-standard detection thresholds, as verified in-house. As a result, chemists consistently receive material that minimizes background reactions and batch-to-batch variability. The appearance holds clear or near-colorless liquid form, maintaining ease of transfer for both bench-scale and bulk syntheses.
The pentanone backbone integrates seamlessly into aromatic substitutions in downstream chemistry. By building our process to minimize side products, we avoid stubborn impurities that can complicate chiral reductions or contaminate final products. Each specification aligns with real-world use in medicinal research, analytical reference standards, and early-stage pilot plant runs. Our own downstream investigations keep us closely tied to the needs of the academic and industrial sectors, so formulation and analytical teams can focus on research—not on cleanup or recrystallization workarounds.
Our colleagues in academic labs, pharmaceuticals, and custom synthesis companies frequently request unique aryl ketones as building blocks for more complex molecules. 4'-Fluorovalerophenone answers a practical demand: the combination of a fluorinated aromatic ring and a versatile aliphatic ketone opens up selective transformations. Researchers developing new CNS-active compounds, for instance, count on this structure as a scaffold for trialing bioisosteric replacements. Contract manufacturing teams can incorporate the compound into intermediate stages without introducing side reactivity common to unsubstituted ketones.
The fluorine at the para-position introduces predictable electronegativity, stabilizing certain reaction intermediates and influencing product yield in directed ortho-lithiation or Friedel–Crafts pathways. Unlike the more volatile methyl or ethyl homologues, the valerophenone side chain adds enough bulk for preparative chromatography or scalable crystallizations. Analytical chemists also point to the single, strong fluorine resonance in NMR as an advantage during method development, ensuring traceability from raw material to finished product. These are not idle marketing points—they show up in direct feedback from scale-up runs and synthetic troubleshooting on our own line.
Workflow efficiency matters. Technicians and operators who have experience with variable quality—cloudiness, excess solvents, or troublesome color—notice the difference that comes from product consistency. There’s no shortcut to achieving that: we run small pilot batches for every new customer specification and perform stability tests under a range of storage conditions, not just room temperature. This matters when you are moving from gram quantities in the lab to multi-kilo lots for industrial use. We keep finished material under inert gas and ship in chemically resistant, sealed containers to preserve both appearance and reactivity, which is especially pertinent if downstream derivatizations are moisture-sensitive or require dry addition protocols.
4'-Fluorovalerophenone may seem only a variant within the family of valerophenones or fluorinated aromatic ketones, but the targeted molecular design plays a major role in reactivity profiles. Fluorine’s influence on aromatic electron density alters how the molecule participates in both nucleophilic and electrophilic substitution reactions. Researchers working on structure-activity relationship (SAR) studies for pharmacological projects often require small inductive and steric adjustments. This specific para-fluoro arrangement allows for exploration of analog libraries without introducing excessive complexity from additional substitution patterns that ortho or meta isomers might cause.
Comparing it with unsubstituted valerophenone, the presence of fluorine at the para position modifies its lipophilicity, volatility, and even potential interactions with biological targets. That’s why medicinal chemists opt for this exact molecule when building libraries for CNS discovery projects—minute changes in physicochemical properties can tip the balance between a viable hit and a dead end. Our own survey of client feedback shows higher yield in halogenation, cross-coupling, and hydrogenation reactions when using our refined material, with minimal byproduct concerns noted in both batch and continuous-flow setups.
Competition in chemical manufacturing has raised awareness around trace impurity management and specification drift. Enterprises relying on non-dedicated synthesis routes or brokered supply chains often report chromatographically indistinct materials that require manual purification. Our dedicated production trains for 4'-Fluorovalerophenone minimize cross-contamination risk with other aryl ketones or unrelated industrial byproducts. The structure’s moderate volatility and lack of strong odor further distinguish it from certain methyl or trifluoromethyl-substituted relatives, which sometimes draw operator complaints or require extra ventilation efforts.
With each product we develop, end-use feedback shapes the way we address demands for scalability, purity, and regulatory compliance. Chemical manufacturers face strict requirements in chromatographically complex molecules like 4'-Fluorovalerophenone. Tolerances around trace metals, water content, and peroxides remain tighter in regulated environments, especially as the compound progresses from early-stage research to potential clinical trials or specialty polymer applications. We maintain line-of-sight traceability for every raw material and processing aid entering our facility, providing clear documentation to meet both internal and regulatory audit standards.
Direct communication between our application chemists and client R&D teams means we anticipate possible scale-up and downstream processing issues before they disrupt timelines. If a project needs material free of polar aprotic solvent traces, for instance, we bring dedicated solvent-stripping and vacuum distillation setups online. Product is sampled throughout processing, logged via LIMS, and archivally retained for comparison in subsequent years. Laboratory managers and project leaders save time thanks to this control, bypassing redundant quality verification steps that can delay research or production.
We invest in operator training and equipment maintenance to decrease batch failures and inconsistent outputs. In doing so, we reduce waste and help customers realize lower total cost per experiment or per synthesis. Packaging options, inert shipping, and short-turnaround fulfillment complete the support framework—each shaped not only by customer requests but also by the same benchmark assessments we apply in our own facility. We routinely test stability under various atmospheric and temperature conditions. This commitment keeps the material as fresh and reliable at its destination as it is at the time of QA release, regardless of journey or storage details.
Synthetic chemists and scale-up engineers know that impurity fingerprints can sideline an entire batch, impacting not just project budgets but also regulatory compliance and safety metrics. In the years since we began direct production of 4'-Fluorovalerophenone, requests for tighter impurity profiles and improved documentation have only increased. Traditional suppliers often overlook low-level impurities that seem “within range” but end up reacting in subsequent steps, causing both technical and regulatory complications.
We map out impurity patterns through multi-technique analysis, going beyond surface-level purity checks. This vigilance delivers consistent melting and boiling point data, as well as reliable 1H, 13C, and 19F NMR character. Practically, this means researchers running multi-step syntheses don’t need to dedicate days to pre-purification, column cleanups, or repetitive analytics. Project management becomes smoother, and costly project delays from unexpected reactivity drop sharply. Every time a kilogram batch is delivered, the technical support and quality characteristics mirror those experienced in the smallest pilot quantities—making it possible to scale projects from discovery to initial application testing without changing suppliers or re-optimizing process parameters.
Upstream, our own R&D team continues to investigate new fluorinated derivatives and process innovations that could further expand the toolbox available to research and industry. Each advance gets fed back into the production environment, closing the loop between lab innovation and process reliability. This approach builds lasting confidence—not only because it reduces rework and complaints but because it lays a technical foundation for future process development built on proven materials.
Our work with 4'-Fluorovalerophenone has not been without challenges. Early attempts at optimizing the fluorination step met with inconsistent yields and stubborn byproduct formation. Collaborating closely with academic partners and industry users allowed us to fine-tune reagent selection and reaction conditions. Today, we employ high-purity starting fluorobenzene derivatives and tight temperature controls, resulting in reproducible performance batch after batch. This feedback cycle offers a unique vantage point—where process improvement directly reflects daily realities in other laboratories and manufacturing environments.
Cleaning and recovering equipment after each synthesis cycle forms part of our daily routine. We learned firsthand how trace residues can contaminate future runs or corrode sensitive components. Our maintenance protocol now schedules frequent inspections and solvent flushes after each bulk production, a decision born out of experience with early contamination events. The lessons we learn help avoid repeated issues and demonstrate accountability—qualities demanded in pharmaceutical, agrochemical, and advanced materials sectors using our intermediates.
Bulk customers in continuous-flow processes bring up unique requirements for low-foaming, non-volatile formulations. To address this, we developed staged solvent evaporation and filtration systems. Our QC chemists routinely benchmark product loss, tracking both chemical and physical metrics to get a true picture of yield, cost efficiency, and environmental impact. These operational changes come not from theory, but through direct hands-on handling of the flows, filters, and final collection vessels.
The range of downstream transformations enabled by 4'-Fluorovalerophenone continues to grow. Polymer researchers develop new fluorinated monomers and crosslinking agents, while medicinal chemists rely on our batch reproducibility for SAR studies and candidate optimization. Every application brings with it a new set of technical constraints, regulatory obligations, and workflow realities. We see our role as more than simply a source. Instead, we support each project with technical insight, documentation packages, and a readiness to adapt process parameters—whether material is bound for a materials research institute or a GMP pharmaceutical pilot suite.
Collaboration between supplier and user often determines the pace of research and the success of scale-up endeavors. We provide direct access to process specialists and quality managers, making it easier to troubleshoot anomalies and identify solutions quickly. This partnership philosophy springs from our roots in hands-on chemical synthesis—not from abstract notions of service, but from real, practical knowledge of what it takes to drive a successful outcome. Moving beyond off-the-shelf formulations, our process teams respond to requests for custom purities, lot sizes, or specific analytical validations, all anchored by concrete experience addressing everything from trace element contamination to API qualification.
Regulatory realities shape nearly every product we produce, including 4'-Fluorovalerophenone. With ongoing changes in environmental, safety, and pharmaceutical statutes, we work to stay ahead of new requirements while avoiding unnecessary bureaucracy or paperwork for our clients. Batch certificates, safety data, and trace impurity analyses are all documented as standard operating procedure—not as last-minute add-ons. Our plant upgrades and staff training programs reflect the belief that preparedness, technical competence, and open communication yield better science, improved safety, and repeatable results over the long term.
Market trends increasingly call for higher specificity in aryl functionalization, cleaner intermediates, and scalable processes. The challenge has never just been about producing the next variant of a standard chemical; it’s about continually improving the reliability, accessibility, and downstream usability of key building blocks like 4'-Fluorovalerophenone. Our manufacturing culture promotes internal innovation—every operator, chemist, and process engineer contributes feedback aimed at squeezing out unnecessary steps, identifying bottlenecks, and making the production environment safer and more resource-efficient.
This culture keeps us responsive to new challenges as they develop. Synthesizing fluorinated ketones under stricter environmental limits, for instance, forced us to re-examine solvent usage, waste stream handling, and recovery practices. The result: improved yields, lower emissions, and higher workplace safety metrics. We run bench-testing of modified processes before scaling, reducing disruption and catching process drift early. During scale-ups, documentation is updated in real time so customers always receive accurate, up-to-date technical support from the first order onward.
Supplier consolidation and increasing regulation place a heavier burden on downstream users, who now need documentation spanning from basic purity analysis to full material traceability. We respond directly by maintaining process files and validation records accessible for regulatory authorities and industrial auditors. This proactive stance protects our clients and keeps project timelines reliable—attributes that matter more than price alone, especially in fields prone to supply interruptions or unforeseen technical challenges.
From a manufacturer’s perspective, every gram of 4'-Fluorovalerophenone reflects both the state of current science and the cumulative lessons collected from thousands of production cycles. Delivering real value involves keeping technical standards high, listening to the evolving needs of users, and allowing workflow realities to guide innovation. End users see this value in improved synthesis outcomes, time saved on troubleshooting, and a smoother path from first experiment to finished application.
Continued investment in process control, quality assurance, and direct technical collaboration ensures each batch meets the highest standards possible. Our commitment to 4'-Fluorovalerophenone production has made us a trusted partner—not only for researchers pursuing the next big therapeutic breakthrough, but also for developers engineering future materials, catalysts, and specialty compounds across a host of industries. The work never pauses, but with the right foundation, every new batch brings better tools to the hands that drive discovery and development worldwide.